NeuroPace (NPCE) EBITDA Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,859.00 |
| Dec 31, 2025 | 286.00 |
| Sep 30, 2025 | 1,951.00 |
| Jun 30, 2025 | -616.00 |
| Mar 31, 2025 | -583.00 |
| Dec 31, 2024 | 313.00 |
| Sep 30, 2024 | 1,887.00 |
| Jun 30, 2024 | 1,022.00 |
| Mar 31, 2024 | -1,482.00 |
| Dec 31, 2023 | 976.00 |
| Sep 30, 2023 | 1,109.00 |
| Jun 30, 2023 | 1,643.00 |
| Mar 31, 2023 | 1,370.00 |
| Dec 31, 2022 | 1,919.00 |
| Sep 30, 2022 | 2,443.00 |
| Jun 30, 2022 | -2,200.00 |
| Mar 31, 2022 | -700.00 |
| Dec 31, 2021 | -2,204.00 |
| Sep 30, 2021 | -1,054.00 |
| Jun 30, 2021 | 1,111.00 |
| Mar 31, 2021 | -3,589.00 |
| Dec 31, 2020 | -1,038.00 |
| Sep 30, 2020 | 8,233.00 |
| Jun 30, 2020 | -4,662.00 |